Standard & Poor’s Ratings Services announced that it has affirmed its ‘A-‘ counterparty credit and financial strength ratings and negative outlook on Amedex Insurance Co.
S&P then said that it had withdrawn the ratings at the company’s request.
“The ratings reflected Amedex’s good business position as a niche provider of major medical products in Latin America, favorable operating performance, and strong capitalization,” said S&P.
“These positive factors are offset by Amedex’s limited size, declining enrollment trends, new business risk through Amedex Bermuda, and high operating expenses, which are the direct consequence of its target market and high level of service provided,” the announcement concluded.
Was this article valuable?
Here are more articles you may enjoy.
Planet-Warming El Niño to Form by September, US Forecasters Say 
Prices for New Cars Have Soared. Here’s One Big Reason Why 
Florida Bills Would Open Door to More Housing in the Everglades, Brownfields 
P/C Statutory Results: The Highs and The Lows 
